Biodesix, Inc. (NASDAQ:BDSX) Q2 2023 Earnings Call Transcript August 7, 2023 Biodesix, Inc. misses on earnings expectations. Reported EPS is $-0.17013 EPS, expectations were $0.21. Operator: Good day and thank you for standing by. Welcome to the Biodesix Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After […]
Veracyte, Inc. today announced that three abstracts focused on the company’s genomic tests for interstitial lung disease and lung cancer will be presented at the American Thoracic Society . | May 1, 2023
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Riverain s ClearRead™ CT with Clear Visual Intelligence™ (CVI) Now Part of UCSD Lung Health Initiative virtual-strategy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from virtual-strategy.com Daily Mail and Mail on Sunday newspapers.